Regulatory Framework for Cannabis: A Position Paper From the American College of Physicians

Ann Intern Med. 2024 Aug;177(8):1104-1105. doi: 10.7326/M24-0638. Epub 2024 Jul 23.

Abstract

Cannabis, also known as marijuana, is the dried flowers, stems, seeds, and leaves of the Cannabis sativa plant. It contains more than 100 compounds, including tetrahydrocannabinol, which has psychoactive effects. Federal law prohibits the possession, distribution, and use of cannabis outside limited research activities, but most states have legalized cannabis for medical or recreational use. However, research into the potential therapeutic and adverse health effects of cannabis has been limited, in part because of the drug's federal legal status. In this position paper, the American College of Physicians (ACP) calls for the decriminalization of possession of small amounts of cannabis for personal use and outlines a public health approach to controlling cannabis in jurisdictions where it is legal. ACP recommends the rigorous evaluation of the health effects and potential therapeutic uses of cannabis and cannabinoids as well as research into the effects of legalization on cannabis use. It also calls for evidence-based medical education related to cannabis and increased resources for treatment of cannabis use disorder.

Publication types

  • Practice Guideline

MeSH terms

  • Cannabinoids / therapeutic use
  • Cannabis*
  • Drug and Narcotic Control / legislation & jurisprudence
  • Humans
  • Legislation, Drug
  • Medical Marijuana* / therapeutic use
  • Public Health / legislation & jurisprudence
  • United States

Substances

  • Medical Marijuana
  • Cannabinoids